IL6 and neoplasm: As for BrafV600E cells, COX-deficiency was associated with a shift in the inflammatory profile at the tumor site, with reduced expression of tumor promoting factors, such as Il6 or Il1b and increased levels of mediators associated with anti-tumor immune pathways (Figure 5C).